The bacterial and viral antigen experts
The Native Antigen Company specialises in the isolation and purification of native viral antigens and native bacterial antigens
Latest Product News
Dengue Virus serotype 2 NS1 protein (DENV2 NS1) is now available to satisfy the unmet need for a highly purified, concentrated protein for use in vaccine development and serological based diagnostic assays. The DENV2 NS1 protein is presented in its native folded state and possesses all post-translational modifications to offer a product which delivers optimal antigenicity.
C. difficile ribotype 027 and 078 toxins
Highly purified toxins and toxoids of C. difficile ribotypes 027 and 078 are now available to support the increasing healthcare focus on combating these hypervirulent strains. To satisfy a broad range of applications in research, vaccine development and IVD manufacturing the products are offered as separate preparations of toxins A & B, are available in a variety of convenient vial sizes and are suitable for long term storage.
C. difficile Toxins and Toxoids A & B
High purity Clostridium difficile toxins A & B are available to satisfy the increasing demands of vaccine research and bioprocess. To meet the needs for use as an immunogen or as a control, toxoid preparations are also available. All are offered as lyophilised preparations to confer long term storage and are available in a choice of vial sizes.
